Eprosartan
Compound with spectra: 1 NMR, and 4 MS (LC)
| SpectraBase Compound ID | 8ARmENIEY9L |
|---|---|
| InChI | InChI=1S/C23H24N2O4S/c1-2-3-6-21-24-14-19(12-18(23(28)29)13-20-5-4-11-30-20)25(21)15-16-7-9-17(10-8-16)22(26)27/h4-5,7-12,14H,2-3,6,13,15H2,1H3,(H,26,27)(H,28,29)/b18-12+ |
| InChIKey | OROAFUQRIXKEMV-LDADJPATSA-N |
| Mol Weight | 424.52 g/mol |
| Molecular Formula | C23H24N2O4S |
| Exact Mass | 424.145678 g/mol |
| Copyright | Copyright © 2018-2025 Wiley-VCH GmbH. All Rights Reserved. |
|---|---|
| Source of Spectrum | Maurer/Meyer/Helfer/Weber c/o Saarland University Homburg/Saar |
| Technique | HCD |
| Copyright | Copyright © 2018-2025 Wiley-VCH GmbH. All Rights Reserved. |
|---|---|
| Source of Spectrum | Maurer/Meyer/Helfer/Weber c/o Saarland University Homburg/Saar |
| Technique | HCD |
| Copyright | Copyright © 2018-2025 Wiley-VCH GmbH. All Rights Reserved. |
|---|---|
| Source of Spectrum | Maurer/Wissenbach/Weber, Saarland University |
| Technique | ITMS |
| Copyright | Copyright © 2018-2025 Wiley-VCH GmbH. All Rights Reserved. |
|---|---|
| Source of Spectrum | Maurer/Wissenbach/Weber, Saarland University |
| Technique | ITMS |
| Copyright | Copyright © 2016-2025 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | DMSO-D6 |
- Eprosartan MS2
- Eprosartan-M (glucuronide) MS3_1
- Eprosartan_neg
Losartan MS2
Losartan potassium
Ethyl 2,3-Dibenzyl-5-methyl-3H-imidazole-4-carboxylate
Butanedioic acid, [(5-oxo-5H-pyrrolo[1,2-a]azepin-3-yl)methylene]-, bis(1,1-dimethylethyl) ester
1H-Benzoimidazole, 2-(2,4-dichlorophenoxymethyl)-1-(4-methylbenzyl)-
1-(p-Chlorobenzyl)-1H-benzimidazole-2-(para - benzoic) acid
Indole-3-ethanamine, 2-(2-thienyl)-
1-(2-methylbenzyl)-2-(phenoxymethyl)-1H-benzimidazole
1-Hex-1-ynyl-3-pentyl-7-propyl-pyrrolo[1,2-c]pyrimidine
[Rp, S]-1-Hydroxy-2-{1'-[N-(1"-<3-bromophenyl>ethyl)imino]ethyl}-[2.2]paracyclophane
| Title | Journal or Book | Year |
|---|---|---|
| Structure elucidation and conformational properties of eprosartan a non peptide Angiotensin II AT1 antagonist | Journal of Pharmaceutical and Biomedical Analysis | 2002 |
This compound is available in the following databases:
Mass Spectra of Designer Drugs 2024
Author: Peter Rösner
This library enables fast and reliable identification of the latest illegal designer drugs. It is updated annually. Learn more.
KnowItAll NMR Spectral Library
Author: Wiley
The KnowItAll NMR Spectral Library offers a comprehensive collection of NMR reference spectra, including NMR, CNMR, and XNMR, and covers a wide range of compounds including organics, polymers, monomers, metabolites, and more. Learn more.
KnowItAll Mass Spectral Library
Author: Wiley
The KnowItAll Mass Spectral Library offers a comprehensive collection of mass spectra, including the renowned Wiley Registry, and access to a wide range of compounds including pure organics, drugs, steroids, additives, geochemicals, petrochemicals, biomarkers, and more. Learn more.
Maurer, Meyer, Helfer, Weber: LC-HR-MS & MS Library of Drugs, Poisons, and Their Metabolites
Author: Hans H. Maurer, Markus Meyer, Andreas G. Helfer, Armin A. Weber
Developed by toxicologist Hans H. Maurer and his team, the Maurer/Meyer/Helfer/Weber LC-HR-MS/MS Library of Drugs, Poisons, and Their Metabolites consists of spectra for parent drugs or poisons, and their metabolites or artifacts, in various compound classification groups. This metabolite-based library helps minimize the risk of false negative LC-MS results. Learn more.